A Quick Question from ny side would be:
When we have quality businesses with well tested business models run by
ethical & efficient Managements, why to take a Plunge in finding
turnarounds & then indulge yourself in uncertainity…
It is my personal opinion/ strategy & not to discourage u.
As far as Reason for u to go ahead with REC for Div Yield & tht too PSU
from Power Sector for which Govt is trying all possible efforts to revive
the drowned & lacklustre sector, I wd have preferred MPS/SQS/Piramal
Enterprise to name a few as these all hv got Promoters who are great
Capital Allocators & I feel immensely safe to park my money with those guys
where Capital Appreciation coupled with Opportunity Size & a cushion of
safety in terms of gud Div Yield…
I prefer to play a sure & safe bet with No Govt/Regulator intervention…
After all its our Personal Choice & thts Y it is known as Personal Finance.
Thnx for initiating a healthy discussion…
Scrips mentioned above are in no way a buy or sell recommendation
On Mar 18, 2016 9:28 PM, “kailasp4u” noreply@forum.valuepickr.com wrote:
kailasp4u
March 18
Thanks @bsahni ji !
Regarding last 3:
Pokarna is at beginning of turnaround! Revenue growth is in line with
management guidance! If turnaround is successful, it can become a great
return generator. So weightage is also low.
REC Ltd. is bought mainly because of very low valuation & dividend yield.
It would be moved out at normalized valuations.
Avanti Feeds, I liked the scrip after going thru its thread and took an
initial position. Then it has dropped, so not added on it.
MCX is added with very long term view of 10+ years. Addition/deletion
into it depends on business performance.
Adding another pharma instead of present ones would tilt portfolio
heavily loaded in pharma sector which is presently 35.5% already. In fact I
would increase in Repco, Force & Tata Elxsi or add another stock which may
benefit from impending infra possibilities or IT sector to reduce portfolio
dependence on pharma.
I generally dont like to have allocation of less than 7-8%. So last 4 in
fact are initial positions with some losses.
Thanks anyway!
Visit Topic or reply to this email to respond.
Previous Replies
bsahni
March 18
Your selection of Stocks seem to be Pretty much decent & it seems that
you definitely would have been clear with your rational behind choosing
these selected Scrips from the Entire Universe.
Sector Allocation also seems to be in Tandem, so as to not being
over-concentrated or diversified.
Only thing IMHO, is that please do ensure while choosing any scrip that
is there any better business available at reasonable valuations with
Promoter’s ethic being already demonstrated during an entire Business
Cycle, including Ups & Downs of the Economy. How much fire in there in
belly of Promoters will be directly proportional to your expected Returns.
As Pointed by Sir Charlie Munger, you cannot expect a Stock to return
more than its Underlying Business.
In my personal capabilities, I would have definitely restricted myself
from last 3 specifically & would have preferred Strides/Ajanta from Pharma
Space.
Views shared hereby are totally personal & do not solicit any Buy or Sell
Recommendation & may be biased as well due to inclination towards the
respective Businesses.
kailasp4u
March 18
Hi All !
This is my portfolio as of today’s closing! I would request your
suggestions, if any, to make it better!
Granules India 14%
Hawkins 14.5%
Lupin 11.5%
Aurobindo Pharma 10.5%
PI Industries 9.5%
Tata Elxsi 8.5%
Repco 7.5%
Force Motors 7.5%
MCX 4.75%
Pokarna 4.25%
REC Ltd. 4%
Avanti Feeds 3%
I am in market since 2008 and portfolio has gone through ups and downs
over time. Repco, Lupin, Hawkins are very old holdings, others are last 1
to 2 year old purchases.
I invite views from experienced people with any specific advice for
modifications.
Regards,
Kailas
Visit Topic or reply to this email to respond.
To stop receiving notifications for this particular topic, click here. To
unsubscribe from these emails, change your user preferences.
